These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11234989)

  • 1. First emergence of glycopeptide-resistant enterococci infections in Greece.
    Routsi C; Platsouka E; Armaganidis A; Paniara O; Roussos C
    Scand J Infect Dis; 2001; 33(1):80. PubMed ID: 11234989
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycopeptide-resistant enterococci in Northern Ireland: first reported outbreak.
    Rizkalla EA; Moore JE; Marshall SA; Murphy PG
    J Antimicrob Chemother; 1997 Oct; 40(4):607-8. PubMed ID: 9372439
    [No Abstract]   [Full Text] [Related]  

  • 3. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
    Kirk M; Hill RL; Casewell MW; Beighton D
    Adv Exp Med Biol; 1997; 418():483-5. PubMed ID: 9331699
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital.
    Maniatis AN; Pournaras S; Kanellopoulou M; Kontos F; Dimitroulia E; Papafrangas E; Tsakris A
    J Clin Microbiol; 2001 Dec; 39(12):4571-4. PubMed ID: 11724887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece.
    Kouppari G; Papadaki H; Arida C; Sakellariou J; Legakis NJ; Papaparaskevas J
    Int J Antimicrob Agents; 2000 Nov; 16(3):254-6. PubMed ID: 11185546
    [No Abstract]   [Full Text] [Related]  

  • 6. The emergence of glycopeptide-resistant Enterococcus faecium in a university hospital in southwestern Greece.
    Kolonitsiou F; Mani V; Parikou H; Trakala M; Dimitracopoulos G; Spiliopoulou I
    Chemotherapy; 2004 Nov; 50(5):245-9. PubMed ID: 15528890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of carriage of glycopeptide-resistant enterococci by at-risk hospitalised patients in Malta.
    Decelis S; Borg MA; Cuschieri P
    Clin Microbiol Infect; 2004 Sep; 10(9):861-2. PubMed ID: 15355423
    [No Abstract]   [Full Text] [Related]  

  • 8. Vancomycin resistant enterococci in hospitals in the United Kingdom--1995.
    Commun Dis Rep CDR Wkly; 1996 Aug; 6(31):267. PubMed ID: 8791882
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
    Abb J
    Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
    Protonotariou E; Dimitroulia E; Pournaras S; Pitiriga V; Sofianou D; Tsakris A
    J Hosp Infect; 2010 Jul; 75(3):225-7. PubMed ID: 20381193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection caused by glycopeptide resistant pathogens].
    Korn SJ; Stille W
    Internist (Berl); 2000 Dec; 41(12):1344-52. PubMed ID: 11189069
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycopeptide resistance in enterococci.
    Méndez-Alvarez S; Pérez-Hernández X; Claverie-Martín F
    Int Microbiol; 2000 Jun; 3(2):71-80. PubMed ID: 11001535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergence of glycopeptide resistant Enterococcus faecium in Algeria: a case report].
    Hamidi M; Ammari H; Ghaffor M; Benamrouche N; Tali-Maamar H; Tala-Khir F; Younsi M; Rahal K
    Ann Biol Clin (Paris); 2013; 71(1):104-6. PubMed ID: 23396433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology and control of multiresistant enterococci.
    Leclercq R
    Drugs; 1996; 52 Suppl 2():47-9. PubMed ID: 8869836
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
    Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
    Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.
    Szűcs Z; Bereczki I; Rőth E; Milánkovits M; Ostorházi E; Batta G; Nagy L; Dombrádi Z; Borbás A; Herczegh P
    J Antibiot (Tokyo); 2020 Sep; 73(9):603-614. PubMed ID: 32409678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.
    Lior L; Litt M; Hockin J; Kennedy C; Jolley BA; Garcia M; Gillis G; Humar A; Campbell I; Brunton J; Dedier H; Conly J
    Can Commun Dis Rep; 1996 Aug; 22(15):125-8. PubMed ID: 8791860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.